Literature DB >> 17975319

In vitro replication of hepatitis D virus using a new construct containing a cDNA dimer of HDV genome.

Farida Behzadian1, Farzaneh Sabahi, Majid Sadeghizadeh, Nader Maghsoudi, Fatemeh Fotouhi, Fatemeh Fotouhi Chahooki, Mohsen Karimi.   

Abstract

BACKGROUND: There is no cell line susceptible to hepatitis D virus (HDV) infection and capable of stable replication of its genome. Different genetic-based approaches have been introduced to initiate HDV replication events so far.
METHODS: In order to construct a replicative model for HDV made from a unique genome sequence, two monomeric units of HDV full-length cDNA were joined together through a four-step cloning scheme. The resulting vector (pcDNA3.1-D2) containing two tandem repeats of HDV cDNA under CMV promoter control was then used in transfection experiments into COS7 and HuH7 cell lines.
RESULTS: HDV replication markers including expression of hepatitis delta antigen (HDAg), the only HDV-specific antigen, and synthesis of antigenomic RNA were shown in both transfected cell lines, indicating initiation of HDV genome replication.
CONCLUSIONS: Our results suggested that pcDNA3.1-D2, a vector containing a cDNA dimer of the HDV genome, originated from a unique full-length HDV molecule that is capable of replicating in cultured cells. This vector can be used conveniently for transfection experiments to study HDV molecular biology. (c) 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17975319     DOI: 10.1159/000110650

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  3 in total

1.  Construction and eukaryotic expression of recombinant large hepatitis delta antigen.

Authors:  Behnaz Forouhar Kalkhoran; Farida Behzadian; Farzaneh Sabahi; Mohsen Karimi; Hesam Mirshahabi
Journal:  Rep Biochem Mol Biol       Date:  2013-10

2.  Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis.

Authors:  Neda Amini; Seyed Moayed Alavian; Ali Kabir; Seyed Hossein Aalaei-Andabili; Seyed Yasser Saiedi Hosseini; Mario Rizzetto
Journal:  Hepat Mon       Date:  2013-01-06       Impact factor: 0.660

3.  Clinical Features and Seroepidemiology of Anti-HDV Antibody in patients With Chronic Hepatitis B Virus Infection in Iran: A Meta-Analysis.

Authors:  Neda Amini; Seyed Moayed Alavian; Ali Kabir; Seyed Yaser Saiedi Hosseini; Seyed Hossein Aalaei Andabili
Journal:  Hepat Mon       Date:  2011-12-20       Impact factor: 0.660

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.